Expert Review of Pharmacoeconomics & Outcomes Research
Papers 1452
1 page of 146 pages (1,452 results)
#1Kamlesh Khunti (Leicester General Hospital)H-Index: 66
#2Melanie J. Davies (Leicester General Hospital)H-Index: 82
Last. Samuel Seidu (Leicester General Hospital)H-Index: 10
view all 3 authors...
Introduction: Early initiated and long-term sustained intensive glucose control is associated with a significantly decreased risk of cardiovascular events and all-cause mortality, over and above th...
#1Luz María Peña Longobardo (UCLM: University of Castilla–La Mancha)H-Index: 2
#2Juan Oliva-Moreno (UCLM: University of Castilla–La Mancha)H-Index: 23
view all 8 authors...
#1Qais Alefan (JUST: Jordan University of Science and Technology)H-Index: 3
#2Esra’a Hamdouni (JUST: Jordan University of Science and Technology)
Last. Karen L. Rascati (University of Texas at Austin)H-Index: 24
view all 5 authors...
#1Zsuzsanna Ida Petykó (Semmelweis University)
#2András Inotai (Semmelweis University)H-Index: 7
Last. Zoltán Kaló (Semmelweis University)H-Index: 18
view all 5 authors...
Introduction: Pharmaceutical research and development (R&D) is costly and only a minority of patients can access innovative medicines due to affordability constraints. Value added medicines (VAMs) can offer potential benefits at significantly lower R&D costs.Areas covered: VAMs may address different health care needs and problems, including off-label use of medicines, poor patient adherence, problems related to polypharmacy, need for home and/or personalized health care services. However, severa...
#1Zhan-Miao Yi (PKU: Peking University)H-Index: 2
#2Peng Men (PKU: Peking University)
Last. Suodi Zhai (PKU: Peking University)H-Index: 16
view all 6 authors...
Background: Both amisulpride and olanzapine are leading treatments for schizophrenia in China. This study aimed to investigate the long-term cost-effectiveness of amisulpride and olanzapine in the treatment of schizophrenia in China.Methods: A decision-analytic Markov model was developed to simulate the lifetime clinical and economic outcomes of schizophrenia treatment from the healthcare payer perspective. The long-term costs and QALYs were estimated. Sensitivity analyses were performed to expl...
Objective: This study aims to provide an up-to-date analysis of the current state of patient access to new drugs in South Korea, focusing on the effect of new review pathways for reimbursement.Methods: We analyzed patients' access to new drugs, listing rate and lead time until listing from marketing authorization. New pathways were defined as "price negotiation waiver", "risk-sharing agreements" and "pharmacoeconomic evaluation exemption".Results: The listing rate for drugs increased after the i...
IntroductionGiven(i) the recent impressive digital transformation worldwide, the importance of data has reached a new dimension. It is, therefore, provocative to ask whether data can save healthcare systems from bankruptcy.Areas covered: We reviewed published examples in the search for the evidence on how the growing amount of data could change the way we used to assess the value of healthcare technologies, ensuring a more holistic approach in the decision-making process while reducing the waste...
Background: Lower gastrointestinal symptoms are common in the general population and it can be difficult to discriminate between inflammatory bowel disease (IBS) and irritable bowel syndrome (IBD) due to overlap of symptoms. The York Faecal Calprotectin Care Pathway (YFCCP) was introduced in 2016 as an alternative to the NICE faecal calprotectin pathway (DG11). This analysis uses the prospective data from the first 1005 patients in the YFCCP. Previous analysis demonstrated the YFCCP may be cost-...
Top fields of study
Quality of life
Health care
Intensive care medicine
Physical therapy
Cost effectiveness